Investigative Site US223 — Los Angeles, California

Investigative Site US223 is a clinical research site located in Los Angeles, California, United States 90033.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Investigative Site US223 has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Hidradenitis Suppurativa (HS).

Sponsors: Incyte Corporation.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site US223?

Investigative Site US223 has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site US223 conducted?

Investigative Site US223 has 2 clinical trials on record, with 1 currently active. Their work covers Hidradenitis Suppurativa (HS).

Is Investigative Site US223 accredited by Crixeo Health?

Investigative Site US223 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Site US223?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.